Resona Asset Management Co. Ltd. Invests $26.76 Million in CME Group Inc. (NASDAQ:CME)

Resona Asset Management Co. Ltd. acquired a new stake in CME Group Inc. (NASDAQ:CMEFree Report) during the 4th quarter, Holdings Channel reports. The institutional investor acquired 115,143 shares of the financial services provider’s stock, valued at approximately $26,758,000.

A number of other large investors also recently bought and sold shares of CME. SJS Investment Consulting Inc. boosted its holdings in shares of CME Group by 570.6% in the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 97 shares in the last quarter. Dunhill Financial LLC lifted its position in CME Group by 188.4% in the third quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 81 shares during the period. New Age Alpha Advisors LLC boosted its holdings in CME Group by 50.0% in the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock valued at $30,000 after purchasing an additional 43 shares in the last quarter. Financial Life Planners purchased a new position in shares of CME Group during the 4th quarter worth approximately $32,000. Finally, Knuff & Co LLC acquired a new stake in shares of CME Group in the 4th quarter valued at approximately $33,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Insider Buying and Selling at CME Group

In other news, insider Julie Winkler sold 11,592 shares of CME Group stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $249.17, for a total value of $2,888,378.64. Following the completion of the sale, the insider now owns 21,885 shares of the company’s stock, valued at $5,453,085.45. The trade was a 34.63 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Suzanne Sprague sold 1,500 shares of the stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $256.83, for a total value of $385,245.00. Following the transaction, the chief operating officer now owns 8,036 shares in the company, valued at $2,063,885.88. This trade represents a 15.73 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 27,076 shares of company stock worth $6,871,496. Insiders own 0.30% of the company’s stock.

Analyst Upgrades and Downgrades

CME has been the topic of a number of recent analyst reports. Citigroup lowered CME Group from a “buy” rating to a “neutral” rating and dropped their price objective for the stock from $255.00 to $250.00 in a report on Monday, January 6th. JPMorgan Chase & Co. increased their price target on shares of CME Group from $209.00 to $212.00 and gave the company an “underweight” rating in a report on Thursday, February 13th. Erste Group Bank upgraded shares of CME Group to a “strong-buy” rating in a research note on Monday, March 17th. Barclays upped their target price on shares of CME Group from $257.00 to $263.00 and gave the stock an “equal weight” rating in a research report on Thursday, February 13th. Finally, Morgan Stanley lifted their price target on shares of CME Group from $256.00 to $263.00 and gave the company an “equal weight” rating in a research report on Wednesday, February 19th. Four analysts have rated the stock with a sell rating, eight have given a hold rating, three have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $241.53.

Read Our Latest Analysis on CME

CME Group Stock Down 5.2 %

CME opened at $254.46 on Friday. The firm has a market cap of $91.70 billion, a P/E ratio of 26.31, a PEG ratio of 6.76 and a beta of 0.53. The business’s fifty day simple moving average is $252.60 and its 200 day simple moving average is $237.31. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $273.42. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CMEGet Free Report) last released its quarterly earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. As a group, equities research analysts anticipate that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Friday, March 7th were paid a $1.25 dividend. This is a boost from CME Group’s previous quarterly dividend of $1.15. This represents a $5.00 annualized dividend and a yield of 1.96%. The ex-dividend date of this dividend was Friday, March 7th. CME Group’s payout ratio is presently 51.71%.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Read More

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.